Re‐Vaya was developed with a focus on science, responding to evolving expectations from formulators who are looking for evidence‐based solutions.
“Re‐Vaya represents a meaningful step forward in how we think about metabolic health,” said Dr. Marcia Da Silva Pinto, Category Manager, Lallemand Bio-Ingredients. “Our goal is to provide a solution that helps people with excess belly fat find metabolic balance while aligning with today’s expectations around trust, transparency, performance and responsibility.”
The introduction of Re-Vaya comes at a time when consumer demands are shifting away from the typical weight loss narrative, reshaping the metabolic health landscape beyond weight management. By focusing on metabolic balance, Re-Vaya is positioned to support increasing demand for sustained metabolic effects across the dietary supplement market.
The supporting study explored metabolic biology using a cutting-edge approach: proteomic analysis of adipose (belly fat) tissue. By mapping changes in hundreds of proteins at once, this technique offers a deeper view of how the body manages inflammation, energy use and metabolic balance.
Re‐Vaya is suitable for dietary supplements, including capsules, tablets, gummies, powders, food, beverages and more, making it adaptable to a wide range of applications.
For more information about Re‐Vaya, please visit https://www.bio-lallemand.com/ or contact Karen Dhanraj, Marketing Manager.
